INCY Incyte Corporation

Healthcare

Price

$112.73

Intrinsic value

$123.86

Buy price

$99.09

Discount

9.0%

Fair (no MOS)

Live signals (1)

Daily bars as of Oct 8, 2026

DRDown-move ReversalBullish ↑
A swing low right after a sharp down-flush, with the bar closing strong - sellers absorbed at the bottom of the flush.
Fired Oct 8, 2026on the latest daily bar41.4% win rate · 1.46x profit factor

A pattern is reported for 5 bars after it fires (the sweet-spot fill window), so an older bar count means the entry has had longer to play out - not that the signal is stronger. Win rate and profit factor are the pattern's backtested averages across the S&P 500, not a forecast for this ticker.

DCF walkthrough

Near-term growth (g1)14.84%

Terminal growth (g2)3.50%

Years of g1 growth4

Discount rate9.00%

Margin of safety20.00%

Operating CF: $1,979,703,000.00
Total debt: $38,267,000.00
Cash & STI: $4,535,739,904.00
Shares out.: 208,216,000

Fair (no MOS)

Intrinsic value$123.88

Buy price (with MOS)$99.10

Current price$112.73

Discount to intrinsic value9.0%

7-step quality scorecard

ROE quality

LOW

Average ROE: 11.3%
Current ROE: 24.9%
Minimum ROE: 0.9%

Debt quality

CONSERVATIVE

Debt / Equity: 0.01x

Moat proxy

MODERATE_PROXY

Cash-flow reliability

Operating CF / Net income: 1.23x

Technical chart

Confluence: WEAK (1/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source: yfinance
Growth (g1) source: revenueCAGR
Valuation model: DCF_OCF
Debt as % of DCF PV: 0.2%
Public economic interest: 100.0%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.